OP
OptimizeRx Corp.
OPRX · NASDAQ
$7.56 -1.95% (-$0.15)
1M -7.90%
Market Cap $146.2M
P/E Ratio 31.77x
Div. Yield -
ROE 3.60%
Bulios Fair Price
$7.36
2.6% downside
Current Price
$7.56
Undervalued Fair Value Overvalued
According to Bulios Fair Price, OPRX is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
78 /100
Cheap P/FCF 7.96x
P/S 1.48x
P/B 1.12x
Growth
89 /100
Growing FCF growth 21.47%
Book val. growth 0.57%
Rev. growth 20.56%
Profitability
71 /100
Strong Net margin 4.66%
Op. margin 11.45%
FCF margin 18.61%
Quality
26 /100
Poor ROE 3.60%
ROA 2.80%
Asset turnover 0.60x
Debt
86 /100
Low Current ratio 5.58x
Int. coverage 2.45x
Net debt/EBITDA -0.30x
Stability
52 /100
Moderate Rev. volatility 7.33%
EPS volatility 95.38%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about OPRX
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Stephen L. Silvestro
Employees
133
Headquarters
Waltham
Upcoming events
05 NOV
Earnings
Upcoming earnings report